Addus homecare EVP Sean Gaffney sells shares worth $47,823

Published 27/02/2025, 22:04
Addus homecare EVP Sean Gaffney sells shares worth $47,823

Sean Gaffney, Executive Vice President and Chief Legal Officer of Addus HomeCare Corp (NASDAQ:ADUS), sold 479 shares of the company’s common stock on February 25. The shares were sold at a price of $99.84 each, totaling $47,823. Following this transaction, Gaffney holds 18,179 shares directly. This sale was conducted under a 10b5-1 plan to cover tax obligations related to the vesting of restricted stock awards. According to InvestingPro’s analysis, Addus HomeCare maintains a GOOD financial health score, operating with moderate debt levels and sufficient cash flows to cover interest payments. For deeper insights into ADUS’s valuation and growth prospects, investors can access the comprehensive Pro Research Report available on InvestingPro.

In other recent news, Addus HomeCare Corporation reported its fourth-quarter 2024 earnings, surpassing expectations with an EPS of $1.38 compared to the forecasted $1.35, and revenue reaching $297.1 million against a forecast of $284.28 million. Despite these positive results, the company’s stock experienced a decline. The company’s recent acquisition of Gentiva and a rate increase in Illinois are expected to bolster earnings in the future. Analyst firms have made adjustments to their price targets for Addus HomeCare, with KeyBanc maintaining an Overweight rating and a $150 target, while Stephens cut its target to $142 but also maintained an Overweight rating. Raymond (NSE:RYMD) James reduced its price target to $120 from $140, citing concerns about potential Medicaid cuts, though it kept an Outperform rating. Addus HomeCare’s strategic focus on mergers and acquisitions remains strong, with a commitment to maintaining a growth trajectory despite potential legislative uncertainties. The company has also emphasized its insulation from potential Medicaid funding reforms, projecting minimal impact on its operations.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.